Kumho HT Acquires Dynano in 'New Drug Development' Merger
[Asia Economy Reporter Ji Yeon-jin] Kumho HT announced on the 27th that it will absorb and merge its affiliate, Dynona.
The company stated, "As Dynona's new drug development enters clinical trials in earnest, Kumho HT aims to clarify its core businesses not only in the automotive lamp sector but also as a global bio-specialized company, thereby enhancing its external credibility."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The extraordinary general meeting of shareholders for the absorption merger will be held at 12:00 AM on June 10 this year at 1st floor of the annex building, Kumho HT Jangseong Plant, Donghwa-myeon, Jangseong-gun, Jeollanam-do.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
